Gene: FAM171B
Official Full Name: family with sequence similarity 171 member Bprovided by HGNC
Gene Summary: Predicted to be located in membrane. Predicted to be active in synapse. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17778 | FAM171B Knockout cell line (HeLa) | Human | FAM171B | 1:3~1:6 | Negative | Online Inquiry |
KO17779 | FAM171B Knockout cell line (HCT 116) | Human | FAM171B | 1:2~1:4 | Negative | Online Inquiry |
KO17780 | FAM171B Knockout cell line (HEK293) | Human | FAM171B | 1:3~1:6 | Negative | Online Inquiry |
KO17781 | FAM171B Knockout cell line (A549) | Human | FAM171B | 1:3~1:4 | Negative | Online Inquiry |
FAM171B Gene Knockout Cell Lines represent a pioneering advancement in genetic research, specifically designed to facilitate the study of the FAM171B gene's functions and its implications in various biological processes. By utilizing CRISPR-Cas9 technology, these cell lines have been genetically modified to exhibit a complete knockout of the FAM171B gene, allowing researchers to investigate the downstream effects of its loss on cellular pathways, signaling, and overall cellular physiology.
The primary function of these knockout cell lines is to provide a robust platform for elucidating the biological roles of the FAM171B gene, which has been implicated in cellular responses to stress and immune regulation. The deletion of FAM171B enables researchers to study phenotypic changes, assess metabolic impacts, and evaluate any alterations in cell signaling processes that could reveal important insights into its role in diseases, particularly those related to immune dysfunction or metabolic disorders.
In research and clinical settings, FAM171B Gene Knockout Cell Lines hold significant importance as they offer invaluable resources for drug development, biomarker discovery, and disease modeling. By understanding how the absence of FAM171B affects cellular dynamics, scientists can identify potential therapeutic targets and develop novel intervention strategies.
What sets our FAM171B Gene Knockout Cell Lines apart from other genetic models is the unparalleled precision of our gene editing process, combined with the broad applicability of these cell lines in both basic and applied research. Unlike alternative models, which may not adequately mimic the physiological conditions found in human cells, our knockout cell lines are generated from human-derived materials, ensuring the relevance and accuracy of research findings.
Researchers and clinicians seeking to deepen their understanding of gene function and its implications in pathology will find immense value in our FAM171B Gene Knockout Cell Lines. As part of our commitment to advancing scientific discovery, we leverage extensive expertise in molecular genetics and cell biology to provide high-quality biological products designed to meet the evolving needs of the research community. Our dedication to innovation and excellence ensures that our customers receive reliable tools that enable groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.